Table 5.
Sleep quality | Sleep duration | |||
---|---|---|---|---|
Betaa | p | Betaa | p | |
Dependent variable: AD-CM | ||||
Young adulthood | 0.011 | 0.880 | 0.135 | 0.054 |
Midlife | − 0.058 | 0.418 | 0.173 | 0.015 |
Current | − 0.013 | 0.871 | < 0.001 | 0.995 |
Dependent variable: AD-CT | ||||
Young adulthood | − 0.002 | 0.970 | 0.008 | 0.894 |
Midlife | − 0.017 | 0.779 | − 0.001 | 0.987 |
Current | − 0.117 | 0.088 | − 0.033 | 0.586 |
Adjusted for age, gender, education, apolipoprotein E ε4 status, vascular risk score, use of sleep pill, Hamilton Depression Rating Score. AD-CT were natural log-transformed to achieve normal distribution
AD-CM Alzheimer’s disease signature region cerebral glucose metabolism, AD-CT Alzheimer’s disease signature region cortical thickness
aPositive beta value means that better sleep quality or decreased duration of sleep is associated with decreased glucose metabolism and/or cortical thickness, respectively